Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TLC Laser Eye Centres (TLC.TO)

PAST TOP PICK
(A top pick Mar 17/04. Up 17%.) Still likes. Haven't gone very far from the breakout of the base, so that expects more.
TOP PICK
Has established a strong base and is out of favor. Has now started a new up leg. Waiting for a pullback to $13 to buy.
BUY ON WEAKNESS
Laser eye treatments are starting a turnaround with newer techniques. FDA approval on a new drug for macular degeneration could make laser treatment a small part.
DON'T BUY
Probably fully priced and competition can easily be built up.
PAST TOP PICK
(Was a top pick July 29/03. Down 9.43 to 8.18%) Competition upped their guidance by 50%, which put a damper on the stock. Still likes.
TOP PICK
Most of their problems have been eliminated. Costs have decreased and revenues have increased. Competition is limited. Great balance sheet.
WATCH
Have diversified their income stream. Revenue is up. Earnings have gone up to $0.01 a share. Hit a double bottom in October and March and then took off. Watch for the $6 level to see if it can break through or is a drop.
DON'T BUY
To have growth potential, new products will be needed.
DON'T BUY
Demand for laser eye surgery may be down.
DON'T BUY
Has a lot of competition. Before buying, would like to see some growth built out.
WEAK BUY
A lot of competition has gone under so its better now, but can only see limited upside.
DON'T BUY
In a tough business. Has lost money for the last 8 years. Has a lot of competition.
DON'T BUY
Have to watch for the strength of the balance sheet.
DON'T BUY
Merger will be good. Still a growth stock, but not as robust. Wait for merger to settle in.
BUY
Good turnaround. Likes what they are doing. Good price.
Showing 16 to 30 of 47 entries